June 2026 Recall: Topics on Parkinsonian Disorders

A landmark 10-year study of over 1,000 Parkinson's patients reveals that nearly one in six initially diagnosed with Parkinson's disease (PD) ultimately receive a different diagnosis—highlighting the fluid nature of PD diagnosis even in real-world clinical settings. The research, led by Valtteri Kassanen from Finland, shows that diagnostic changes often emerge within the first two years and are triggered by atypical features like poor levodopa response, vertical gaze palsy, or a normal dopamine transporter (DAT) scan—contrary to the assumption that early red flags predict instability. Crucially, about 5% of patients remain in a state of 'clinically uncertain Parkinsonian syndrome' despite extensive follow-up, underscoring the limits of current diagnostic criteria. This challenges the notion of PD as a fixed diagnosis and calls for a more humble, dynamic approach in clinical communication. The episode further explores the critical distinction between dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), showing they differ not only in symptom timing but also in underlying pathology—DLB features more amyloid and tau, faster cognitive decline, and greater neuroleptic sensitivity. Meanwhile, Dan Weintraub’s data from the PPMI cohort reveals that long-term dementia risk in PD may be closer to 10% at 10 years, not the previously assumed 80%, offering meaningful reassurance.